J&J, AstraZeneca, Novo Nordisk and Roche are among the companies that might take a hit from the soon-to-be-enacted fees, ...
Trump's tariffs could derail Europe's 2025 growth, say top Wall Street analysts. Goldman Sachs sees eurozone GDP at 0.7%, ...
That morning latte and avocado toast could get a lot pricier.
Novo Nordisk said on Wednesday it plan to file its experimental next-generation obesity drug CagriSema for regulatory ...
Wegovy maker Novo Nordisk on Wednesday forecast slower sales growth for 2025 than 2024, a blow that is likely to deepen ...
Novo’s Wegovy and Ozempic are among the most closely watched new medications in recent history, but face serious competition ...
With the respite in U.S. tariffs on key countries, investors could turn their attention to earnings. But Alphabet earnings ...
19h
Enveric Biosciences’ (NASDAQ:ENVB) wholly-owned subsidiary, Akos Biosciences, Inc., entered into two licensing agreements ...
Palantir Technologies stock is trading at its highest level on record after the company posted a big beat with its fourth-quarter results. Earnings per share were up annually by 75% to 14 cents, ...
Global Biopharmaceuticals Market Depth of Insights Ethnography’s Contribution to Consumer Behavior
Request To Download Free Sample of This Strategic Report @ Highlighted with 78 tables and 119 figures, this 215-page report ?Global Biopharmaceuticals Market 2023-2033 by Product Type, Testing ...
Request To Download Free Sample of This Strategic Report @ Highlighted with 36 tables and 83 figures, this 153-page report ?North America Biopharmaceuticals Market 2023-2033 by Product Type, Testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback